Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$38.88 - $45.31 $11,625 - $13,547
-299 Reduced 23.88%
953 $42,000
Q3 2021

Oct 08, 2021

BUY
$38.79 - $43.16 $19,395 - $21,580
500 Added 66.49%
1,252 $48,000
Q2 2020

Jul 23, 2020

BUY
$37.87 - $43.58 $28,478 - $32,772
752 New
752 $31,000
Q2 2019

Aug 07, 2019

SELL
$39.4 - $42.7 $1,457 - $1,579
-37 Closed
0 $0
Q1 2019

Apr 23, 2019

BUY
$38.57 - $42.69 $1,427 - $1,579
37 New
37 $2,000
Q4 2017

May 02, 2018

SELL
$35.34 - $41.9 $2,155 - $2,555
-61 Closed
0 $0
Q3 2017

May 02, 2018

SELL
$39.44 - $41.55 $11,832 - $12,465
-300 Reduced 83.1%
61 $1,000
Q1 2017

May 02, 2018

SELL
N/A
-200 Reduced 35.65%
361 $13,000
Q4 2016

Mar 14, 2018

BUY
N/A
561
561 $21,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.